Cargando…

The Polypharmacological Effects of Cannabidiol

Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753). This naturally occurring secondary metabolite does not induce intoxication or exhibit the characteristic profile of drugs of abuse from cannabis like Δ(9)-tetrahydrocannabinol (∆(9)-THC) does. In contrast to ∆(9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castillo-Arellano, Jorge, Canseco-Alba, Ana, Cutler, Stephen J., León, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096752/ https://www.ncbi.nlm.nih.gov/pubmed/37050032 http://dx.doi.org/10.3390/molecules28073271

Ejemplares similares

Polypharmacology: promises and new drugs in 2022
por: Ryszkiewicz, Piotr, et al.
Publicado: (2023)

Advances in Computational Polypharmacology
por: Feldmann, Christian, et al.
Publicado: (2022)

Computational polypharmacology comes of age
por: Rastelli, Giulio, et al.
Publicado: (2015)

Structural and Functional View of Polypharmacology
por: Moya-García, Aurelio, et al.
Publicado: (2017)

Epigenetic polypharmacology: from combination therapy to multitargeted drugs
por: de Lera, Angel R., et al.
Publicado: (2016)

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
por: Papa, Alessandro, et al.
Publicado: (2022)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Automated design of ligands to polypharmacological profiles
por: Besnard, Jérémy, et al.
Publicado: (2012)

Exploiting kinase polypharmacology for nerve regeneration
por: Al-Ali, Hassan, et al.
Publicado: (2016)

How polypharmacologic is each chemogenomics library?
por: Ni, Eric, et al.
Publicado: (2020)

Polypharmacology of small molecules targeting the ubiquitin–proteasome and ubiquitin-like systems
por: Amelio, Ivano, et al.
Publicado: (2015)

The Mycobacterium tuberculosis Drugome and Its Polypharmacological Implications
por: Kinnings, Sarah L., et al.
Publicado: (2010)

Curation and Analysis of Multitargeting Agents for Polypharmacological Modeling
por: Reddy, A. Srinivas, et al.
Publicado: (2014)

The kinase polypharmacology landscape of clinical PARP inhibitors
por: Antolin, Albert A., et al.
Publicado: (2020)

Privileged Structures and Polypharmacology within and between Protein Families
por: Meyers, Joshua, et al.
Publicado: (2018)

In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014)

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
por: Chu, Ming, et al.
Publicado: (2018)

High Impact: The Role of Promiscuous Binding Sites in Polypharmacology
por: Cerisier, Natacha, et al.
Publicado: (2019)

Detecting similar binding pockets to enable systems polypharmacology
por: Duran-Frigola, Miquel, et al.
Publicado: (2017)

Polypharmacology in Precision Oncology: Current Applications and Future  Prospects
por: Antolin, Albert A., et al.
Publicado: (2016)

Discovery of talmapimod analogues as polypharmacological anti-inflammatory agents
por: Liu, Wandong, et al.
Publicado: (2019)

KRIPO – a structure-based pharmacophores approach explains polypharmacological effects
por: Ritschel, Tina, et al.
Publicado: (2014)

Antidepression and Prokinetic Effects of Paeoniflorin on Rats in the Forced Swimming Test via Polypharmacology
por: Mu, Dao-zhou, et al.
Publicado: (2020)

Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases
por: Apsel, Beth, et al.
Publicado: (2008)

Elucidating Polypharmacological Mechanisms of Polyphenols by Gene Module Profile Analysis
por: Li, Bin, et al.
Publicado: (2014)

Drug-target and disease networks: polypharmacology in the post-genomic era
por: Masoudi-Nejad, Ali, et al.
Publicado: (2013)

Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases
por: Baby, Bincy, et al.
Publicado: (2016)

Polypharmacology Within the Full Kinome: a Machine Learning Approach
por: Jones, Derek, et al.
Publicado: (2018)

Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets
por: Saqib, Uzma, et al.
Publicado: (2018)

A simple mathematical approach to the analysis of polypharmacology and polyspecificity data
por: Maggiora, Gerry, et al.
Publicado: (2017)

Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology
por: Kampen, Stefanie, et al.
Publicado: (2021)

Evolution of kinase polypharmacology across HSP90 drug discovery
por: Antolin, Albert A., et al.
Publicado: (2021)

Effects of Cannabidiol on Locomotor Activity
por: Calapai, Fabrizio, et al.
Publicado: (2022)

Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation
por: Olson, Annabel T., et al.
Publicado: (2023)

Polypharmacology guided drug repositioning approach for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2023)

Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation
por: Olson, Annabel T., et al.
Publicado: (2023)

Modularity in Protein Complex and Drug Interactions Reveals New Polypharmacological Properties
por: Nacher, Jose C., et al.
Publicado: (2012)

Mining Significant Substructure Pairs for Interpreting Polypharmacology in Drug-Target Network
por: Takigawa, Ichigaku, et al.
Publicado: (2011)

Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
por: Hammam, Kahina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_07mj9vbvvv1t075nopk5dqtbep